TCR2 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner TANG KEVIN C
TCR2 Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(0%),TANG CAPITAL MANAGEMENT, LLC(0%), etc.
TCR2 Therapeutics | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
TCR2 Therapeutics | EFFECT: Others
TCR2 Therapeutics | EFFECT: Others
TCR2 Therapeutics | EFFECT: Others
TCR2 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner UBS Oncology Impact Fund L.P.
TCR2 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner MPM SunStates Fund, L.P.
TCR2 Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner MPM BioVentures 2014, L.P.
TCR2 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GADICKE ANSBERT
TCR2 Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
TCR2 Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
TCR2 Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
TCR2 Therapeutics | S-8 POS: S-8 POS
TCR2 Therapeutics | S-8 POS: S-8 POS
TCR2 Therapeutics | S-8 POS: S-8 POS
TCR2 Therapeutics | S-8 POS: S-8 POS
TCR2 Therapeutics | S-8 POS: S-8 POS
TCR2 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Allen Andrew R
TCR2 Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Tomasello Shawn
No Data
No Data